CompletedNCT04618250
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.
SchizophreniaOtherOver 18 Years
- Countries
- Denmark
- Sponsor
- University of Copenhagen
- Condition
- Schizophrenia
WithdrawnNCT04430959
This study exists to better understand the safety of blood tests and biological markers and how manageable it feels in practice. Researchers are trying to understand how people respond to blood tests and biological markers in practice and what may need to be adjusted.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- The University of Texas Health Science Center, Houston
- Condition
- Depression
CompletedNCT02845440
This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand how people respond to smoking support or smoking-related treatment in practice and what may need to be adjusted.
DepressionOtherOver 18 Years
- Countries
- United States
- Sponsor
- Massachusetts General Hospital
- Condition
- Depression
CompletedNCT04417049
This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- Canada
- Sponsor
- University Health Network, Toronto
- Condition
- Depression
CompletedNCT01986101
This study exists to compare options and see whether the medication SM-13496 offers something meaningfully different. Researchers are trying to understand how people respond to the medication SM-13496 in practice and what may need to be adjusted.
DepressionOtherFrom 18 Years to 74 Years
- Countries
- Japan, Lithuania, Malaysia, Philippines, Russian Federation, Slovakia, Taiwan, Ukraine
- Sponsor
- Sumitomo Pharma Co., Ltd.
- Condition
- Depression
CompletedNCT01986114
This study exists to understand how the medication SM-13496 holds up over time after the earliest research stage. Researchers are trying to understand how people respond to the medication SM-13496 in practice and what may need to be adjusted.
BipolarityOtherFrom 18 Years to 74 Years
- Countries
- Japan, Lithuania, Malaysia, Philippines, Russian Federation, Slovakia, Taiwan, Ukraine
- Sponsor
- Sumitomo Pharma Co., Ltd.
- Condition
- Bipolarity
CompletedNCT03630822
This study exists to understand how acceptance and commitment therapy, a talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherOver 18 Years
- Countries
- France
- Sponsor
- Assistance Publique Hopitaux De Marseille
- Condition
- Schizophrenia
CompletedNCT00484471
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can better prevent setbacks and support longer-term stability.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- China, Philippines, Taiwan, Thailand
- Sponsor
- Korea Otsuka International Asia Arab
- Condition
- Bipolarity
CompletedNCT03156504
This study exists to see whether the medication Ketamine can play a useful role in care. Researchers are trying to understand whether the medication Ketamine can better support energy, concentration, and everyday functioning.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Mayo Clinic
- Condition
- Depression
CompletedNCT03959735
This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
DepressionOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- King's College London
- Condition
- Depression
TerminatedNCT02707276
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
DepressionOtherFrom 55 Years to 85 Years
- Countries
- United States
- Sponsor
- Mclean Hospital
- Condition
- Depression
CompletedNCT03408873
This study exists to see whether psychoeducation, a guided learning and support program, can play a useful role in care. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can work better when mental health difficulties overlap with substance use.
BipolarityOtherOver 18 Years
- Countries
- United States
- Sponsor
- Martha Sajatovic
- Condition
- Bipolarity
CompletedNCT03386851
This study exists to better understand the safety of a medication treatment and how manageable it feels in practice. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherOver 19 Years
- Countries
- South Korea
- Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Condition
- Schizophrenia
CompletedNCT00159783
This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.
BipolarityOtherOver 18 Years
- Countries
- Global
- Sponsor
- Organon and Co
- Condition
- Bipolarity
CompletedNCT00145509
This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
BipolarityOtherOver 18 Years
- Countries
- Global
- Sponsor
- Organon and Co
- Condition
- Bipolarity
CompletedNCT01498770
This study exists to see whether the medication Asenapine can play a useful role in care. Researchers are trying to understand what the medication Asenapine could change in day-to-day care and decision-making.
BipolarityOther
- Countries
- Global
- Sponsor
- Organon and Co
- Condition
- Bipolarity
CompletedNCT01495741
This study exists to compare options and see whether the medication Asenapine offers something meaningfully different. Researchers are trying to understand what the medication Asenapine could change in day-to-day care and decision-making.
BipolarityOtherOver 18 Years
- Countries
- Global
- Sponsor
- Organon and Co
- Condition
- Bipolarity
TerminatedNCT03206463
This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
BipolarityOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Yale University
- Condition
- Bipolarity
CompletedNCT04222816
This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.
BipolarityOtherFrom 18 Years to 60 Years
- Countries
- India
- Sponsor
- All India Institute of Medical Sciences, Bhubaneswar
- Condition
- Bipolarity
TerminatedNCT02726659
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.
DepressionOtherFrom 18 Years to 45 Years
- Countries
- Canada
- Sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Condition
- Depression
CompletedNCT04098497
This study exists to understand how acceptance and commitment therapy, a talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can make support easier to access outside standard clinic visits.
BipolarityOtherOver 18 Years
- Countries
- United States
- Sponsor
- University of Wisconsin, Madison
- Condition
- Bipolarity
CompletedNCT03661333
This study exists to see whether the medication Dialectical is workable and worth testing more broadly. Researchers are trying to understand how people respond to the medication Dialectical in practice and what may need to be adjusted.
BipolarityOtherFrom 13 Years to 19 Years
- Countries
- Canada
- Sponsor
- Sunnybrook Health Sciences Centre
- Condition
- Bipolarity
CompletedNCT01503489
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
BipolarityOtherFrom 18 Years to 80 Years
- Countries
- Spain
- Sponsor
- Hospital Clinic of Barcelona
- Condition
- Bipolarity
CompletedNCT04095559
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.
BipolarityOtherOver 18 Years
- Countries
- Switzerland
- Sponsor
- University Hospital, Basel, Switzerland
- Condition
- Bipolarity
CompletedNCT02184767
This study exists to explore whether a medication treatment could improve care and understanding. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.
BipolarityOtherFrom 10 Years to 17 Years
- Countries
- United States
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Condition
- Bipolarity